Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology
Christopher V. Lutman, Laura Jean Havrilesky, Janiel M. Cragun et al. · Gynecologic Oncology · 2006
Cited by 204 works. doi:10.1016/j.ygyno.2005.11.032
Authors
- Christopher V. Lutman
- Laura Jean Havrilesky
- Janiel M. Cragun
- Angeles Alvarez Secord
- Brian Calingaert
- Andrew Berchuck
- Daniel L. Clarke‐Pearson
- John T. Soper
References
- Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study
- A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
- Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling
- Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer
- Low-risk corpus cancer: Is lymphadenectomy or radiotherapy necessary?
- Staging Laparotomy for Endometrial Carcinoma: Assessment of Retroperitoneal Lymph Nodes
- Long-Term Survival of Intermediate Risk Endometrial Cancer (Stage IG3, IC, II) Treated with Full Lymphadenectomy and Brachytherapy without Teletherapy
- Occult Lymph Node Metastases Detected by Cytokeratin Immunohistochemistry Predict Recurrence in Node-Negative Endometrial Cancer
- The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer